GlassScriptPhysician profile
Saul Benitez
NPI 1386971794
$7,528.15
in general payments reported to CMS, 2019-2025
27 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,695 · 2022: $2,116 · 2023: $2,148 · 2024: $1,367 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,717.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,422.04 | 2021-2024 | |
| Abbott Laboratories | $1,265.06 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Jot Dx |
| Cvrx, INC. | $539.26 | 2021-2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $436.38 | 2022-2025 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $424.18 | 2021-2024 | Lifevest |
| Medtronic, INC. | $361.96 | 2022-2025 | Corevalve Evolut R |
| Alnylam Pharmaceuticals INC. | $339.54 | 2021-2024 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $326.51 | 2021-2023 | Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $322.97 | 2021-2024 | Xarelto |
| Pfizer INC. | $315.27 | 2021-2024 | |
| Actelion Pharmaceuticals US, INC. | $310.22 | 2021-2024 | Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $297.03 | 2021-2024 | |
| United Therapeutics Corporation | $249.42 | 2021-2024 | Tyvaso, Orenitram |
| Atricure, INC. | $173.77 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.16 | 2022-2024 | Jardiance |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $144.66 | 2024 | |
| Daiichi Sankyo INC. | $104.21 | 2023-2024 | Injectafer |
| Abiomed | $89.31 | 2022-2023 | Impella |
| Merck Sharp & Dohme LLC | $66.18 | 2024 | Verquvo, Winrevair |
| Boston Scientific Corporation | $54.21 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $32.27 | 2024 | Arcalyst |
| Johnson & Johnson Health Care Systems INC. | $28.46 | 2024 | Opsumit, Uptravi |
| Hologic Sales and Service, LLC | $16.96 | 2021 | |
| Irhythm Technologies, INC. | $16.57 | 2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $15.52 | 2022 | |
| Scpharmaceuticals INC. | $14.27 | 2024 | |
| Amarin Pharma, INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saul Benitez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.